• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析患者骨骼中铝的无声且渐进性蓄积,无明确的组织学骨软化表现。

Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients.

作者信息

Suzuki M, Hirasawa Y, Tanizawa T

机构信息

Kidney Center, Shinrakuen Hospital, Niigata, Japan.

出版信息

Clin Nephrol. 1995 Nov;44 Suppl 1:S51-5.

PMID:8608664
Abstract

The aluminum (Al) contents of the tap water and the dialysis fluid in our center had proven to be less than 10 micrograms/l during more than 10 years. We evaluated the Al content, stainable Al, and the histomorphometry of the bone biopsy specimens from the 23 chronic renal failure patients on dialysis. The plasma Ca, P, Mg, ALP, C-PTH, and Al levels except calcitonin (CT, r = 0.442, p < 0.05) had no significant relationship to the hemodialysis (HD) duration. Their bone histologies were classified as osteitis fibrosa (OF) in 9, mild type (MILD) in 11, mixed type (MIXED) in 2, and osteomalacia (OM) in 1. The stainable Al% on the trabecular bone surface showed a positive correlation with HD duration (r = 0.569, p < 0.001), with the bone Al content (r = 0.455, p < 0.05), and with the bone Al/Ca ratio (r = 0.668, p < 0.01), respectively. The bone Al, Ca and Mg content did not correlated with HD duration and with plasma Al levels, although the bone Al/Ca ratio showed a strong correlation with HD duration (r = 0.675, p < 0.01) and with plasma Al levels (r = 0.719, p < 0.001). In the histomorphometric parameters, plasma Al levels, stainable Al, bone Al content, as well as bone Al/Ca ratio had no significant correlation with the osteomalacic aspects. Thus, our observations revealed that the Al accumulation in the bones was latent and progressing without definite osteomalacic changes, even though the dialysate Al concentration was under the critical level. Other Al invasion roots besides dialysis fluid should be regarded, including oral intake of Al-containing phosphate binders or other gastrointestinal medicines, as well as food content.

摘要

在过去十多年里,我们中心的自来水和透析液中的铝(Al)含量经证实均低于10微克/升。我们评估了23例接受透析的慢性肾衰竭患者骨活检标本的铝含量、可染色铝以及组织形态计量学指标。除降钙素(CT,r = 0.442,p < 0.05)外,血浆钙、磷、镁、碱性磷酸酶(ALP)、全段甲状旁腺激素(C-PTH)和铝水平与血液透析(HD)时长均无显著相关性。其骨组织学类型分为纤维性骨炎(OF)9例、轻度类型(MILD)11例、混合型(MIXED)2例、骨软化症(OM)1例。小梁骨表面的可染色铝百分比与HD时长(r = 0.569,p < 0.001)、骨铝含量(r = 0.455,p < 0.05)以及骨铝/钙比值(r = 0.668,p < 0.01)分别呈正相关。骨铝、钙和镁含量与HD时长及血浆铝水平均无相关性,尽管骨铝/钙比值与HD时长(r = 0.675,p < 0.01)和血浆铝水平(r = 0.719,p < 0.001)呈强相关。在组织形态计量学参数方面,血浆铝水平、可染色铝、骨铝含量以及骨铝/钙比值与骨软化症方面均无显著相关性。因此,我们的观察结果显示,尽管透析液铝浓度低于临界水平,但骨骼中的铝蓄积是潜在的且在进展,并无明确的骨软化症改变。应考虑除透析液之外的其他铝侵入途径,包括口服含铝的磷结合剂或其他胃肠道药物以及食物中的铝含量。

相似文献

1
Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients.慢性血液透析患者骨骼中铝的无声且渐进性蓄积,无明确的组织学骨软化表现。
Clin Nephrol. 1995 Nov;44 Suppl 1:S51-5.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
J Bone Miner Res. 1988 Jun;3(3):259-67. doi: 10.1002/jbmr.5650030304.
4
Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
J Bone Miner Res. 1986 Oct;1(5):391-8. doi: 10.1002/jbmr.5650010503.
5
Low serum aluminum values in dialysis patients with increased bone aluminum levels.骨铝水平升高的透析患者血清铝值较低。
Clin Nephrol. 1998 Aug;50(2):69-76.
6
Bone aluminum and histomorphometric features of renal osteodystrophy.肾性骨营养不良的骨铝及组织形态计量学特征
J Clin Endocrinol Metab. 1982 Mar;54(3):539-46. doi: 10.1210/jcem-54-3-539.
7
Bone histomorphometrical analysis in patients on long-term dialysis treatment for more than ten years.对接受长期透析治疗超过十年的患者进行骨组织形态计量学分析。
Osaka City Med J. 1998 Dec;44(2):133-53.
8
Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.透析患者骨骼中铝的蓄积导致骨质流失。
J Lab Clin Med. 1986 Jun;107(6):481-7.
9
Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy.
Clin Neuropathol. 1996 Nov-Dec;15(6):342-7.
10
Review of dialysate calcium concentration in hemodialysis.血液透析中透析液钙浓度的综述。
Hemodial Int. 2006 Oct;10(4):326-37. doi: 10.1111/j.1542-4758.2006.00125.x.